Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial.
about
Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models.Novel vaccination approaches to prevent tuberculosis in childrenThe Cross-species Mycobacterial Growth Inhibition Assay (MGIA) Project 2010-2014.Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.What Have We Learnt about BCG Vaccination in the Last 20 Years?Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease.Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?Next-Generation Vaccines Based on Bacille Calmette-Guérin.Deletion of BCG Hip1 protease enhances dendritic cell and CD4 T cell responses.The current status, challenges, and future developments of new tuberculosis vaccines.Adjunctive use of celecoxib with anti-tuberculosis drugs: evaluation in a whole-blood bactericidal activity modelFuture Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine
P2860
Q33614952-59ED00FC-3EB9-44AC-8FEC-8322A17C8318Q33801426-E5A66F83-5C74-4D00-A8CA-646EFA09182DQ38682059-09671154-DE1B-48A6-BA4E-4288F6542A7BQ40116835-4EAB47C0-AC32-432D-A606-10C39079A721Q41684091-B54DDB32-0738-4B76-9F18-1D1C6A6F67D6Q46262252-0832900C-12F3-4E33-8283-D7097700837FQ47834561-D7A05060-7BC9-46DC-870B-A77B0FC98789Q49829375-69D009C3-114D-4A6E-B387-4A2FD0FFF152Q49973045-7603E529-4649-4878-9AC9-FAC96D7FE019Q52337140-8715A24B-7A32-43D6-BDCF-F2802A569C7BQ57929304-D2B0E2A4-79BE-4411-A6D5-350542FF1697Q58553770-8422C981-FFDE-49B6-BC22-57ADD34596EF
P2860
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety and Immunogenicity of t ...... First-in-human Phase 1 Trial.
@en
Safety and Immunogenicity of t ...... First-in-human Phase 1 Trial.
@nl
type
label
Safety and Immunogenicity of t ...... First-in-human Phase 1 Trial.
@en
Safety and Immunogenicity of t ...... First-in-human Phase 1 Trial.
@nl
prefLabel
Safety and Immunogenicity of t ...... First-in-human Phase 1 Trial.
@en
Safety and Immunogenicity of t ...... First-in-human Phase 1 Trial.
@nl
P2093
P2860
P1433
P1476
Safety and Immunogenicity of t ...... First-in-human Phase 1 Trial.
@en
P2093
Alan Aderem
Aldin Turan
Anne A Gershon
Asmir Selimovic
Azra Blazevic
Barbara Shepherd
Bruce McClain
Daniel E Zak
Daniel F Hoft
David A Hokey
P2860
P304
P356
10.1016/J.EBIOM.2016.04.010
P577
2016-04-19T00:00:00Z